Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Akston Biosciences and LakePharma have established a strategic partnership.
read more
Tuesday, February 24, 2026
Akums Drugs & Pharmaceuticals Ltd. has received European Union Good Manufacturing Practice (EU GMP) certification for two of its production sites in India.
read more
Wednesday, August 30, 2017
Alamo Pharma Services will begin outsourcing trainers and training materials to help companies optimize the training and development opportunities.
read more
Thursday, August 17, 2017
Alamo Pharma Services has formed a specialized division of the company that offers partner organizations recruiting services.
read more
Albek de Mexico is voluntarily recalling all lots and all brands of hand sanitizer currently in US distribution to the consumer level.
read more
Wednesday, April 04, 2018
Albemarle announced the completion of the previously announced sale of its polyolefin catalysts and components business to W. R. Grace & Co. in a cash transaction valued at approximately $416 million.
read more
Tuesday, September 10, 2019
Albemarle Fine Chemistry Services announced the expansion of its operations at its Tyrone, Pennsylvania custom manufacturing facility.
read more
Friday, November 18, 2022
Albert Labs International Corp. has signed a Letter of Intent (LOI) with full-service Contract-Research Organization (CRO), iNGENu, to carry out the Company's first in-human study of its primary drug target, KRN-101.
read more
Wednesday, February 03, 2016
Eleven Biotherapeutics and Albumedix have entered into an agreement that will see Albumedix acquire Eleven’s proprietary Supermin® albumin variant assets.
read more
Wednesday, December 07, 2016
Albumedix has entered into a collaborative research agreement with the New York University (NYU) School of Medicine. The collaboration will explore the potential of novel applications of Albumedix’s albumin-based drug delivery platform, Veltis®, to ...
read more
Wednesday, February 24, 2016
Albumedix has announced new data that supports an exclusive agreement with ThioLogics, a UCL Business (UCLB) company, to commercialize the next generation of stable albumin drug conjugates.
read more
Albumedix announced the CBER has accepted a Drug Master File (DMF) submission for the company’s Recombumin Elite.
read more
Jonas Skjødt Møller is Rosholm’s successor as Chief Executive Officer effective July 1, 2020.
read more
Wednesday, March 31, 2021
Albumedix announced they have entered into a distribution agreement with established and well recognized reagent supplier FUJIFILM Wako.
read more
Albumedix has announced that its albumin-based VELTIS® half-life extension technology is being used by CSL Behring in IDELVION®, a therapy recently authorized for the treatment of haemophilia B in the U.S.
read more